You have 9 free searches left this month | for more free features.

PK/PD

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

Not yet recruiting
  • Metastatic Lung Cancer
  • +2 more
  • Tusamitamab ravtansine
  • Rotterdam, Netherlands
    Erasmus MC
Jan 26, 2023

Mechanically Ventilated Patients Trial in Wuhan (Remimazolam besylate)

Not yet recruiting
  • Mechanically Ventilated Patients
  • Remimazolam besylate
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Nov 23, 2023

Cigarette Smoking-Related Carcinoma Trial (Vape device, Joint, Marijuana via vape device)

Not yet recruiting
  • Cigarette Smoking-Related Carcinoma
  • Vape device
  • +3 more
  • (no location specified)
Sep 19, 2023

Neonatal Infection Trial in Aurora (Amoxicillin, Cephalexin)

Enrolling by invitation
  • Neonatal Infection
  • Aurora, Colorado
    Children's Hospital Colorado
Nov 2, 2022

The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal

Completed
  • Fungal Infection
  • Deoxycholic acid amphotericin B
  • Nanjing, Jiangsu, China
  • +1 more
Nov 29, 2022

Healthy Trial in Mahesana (Omalizumab 150mg)

Recruiting
  • Healthy
  • Omalizumab 150mg
  • Mahesana, Gujarat, India
    Registered BE centre
Nov 4, 2022

Gout, Hyperuricemia Trial in United States (dontinurad, dotinurad + allopurinol, allopurinol)

Recruiting
  • Gout
  • Hyperuricemia
  • Clearwater, Florida
  • +3 more
Sep 20, 2023

Hereditary Angioedema Trial in Adelaide (ADX-324, Placebo)

Recruiting
  • Hereditary Angioedema
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jan 10, 2023

Healthy Trial in Ahmedabad, Mahesana (ADL-018, US-licensed XOLAIR, EU-Approved XOLAIR)

Recruiting
  • Healthy
  • ADL-018
  • +2 more
  • Ahmedabad, Gujarat, India
  • +1 more
Sep 29, 2022

Healthy Trial in Shanghai (SR1375 capsules, Placebo)

Active, not recruiting
  • Healthy
  • SR1375 capsules
  • Placebo
  • Shanghai, China
    Phase I clinical laboratory of Huashan Hospital
Jul 14, 2022

Renal Replacement Therapy Trial in Guangzhou (HSK36273, Heparin sodium)

Not yet recruiting
  • Renal Replacement Therapy
  • Guangzhou, China
    The First Affiliated Hospital of Sun Yat-sen University
Nov 1, 2022

Thrombosis Trial in Perth (SRSD107, Placebo)

Not yet recruiting
  • Thrombosis
  • Perth, Other (Non U.s.), Australia
    Linear Clinical Research
Nov 2, 2023

Plaque Psoriasis Trial in London, Manchester (ONO-4685, Placebo)

Recruiting
  • Plaque Psoriasis
  • Chisinau, Moldova, Republic of
  • +2 more
Sep 29, 2022

Opioid Overdose Trial (intradermal naloxone, microneedle injection)

Not yet recruiting
  • Opioid Overdose
  • intradermal naloxone
  • microneedle injection
  • (no location specified)
May 24, 2023

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Nov 29, 2022

Propofol in Patients With Severe Burns

Terminated
  • Anesthesia
  • +2 more
  • Santiago, RegiĆ³n Metropolitana, Chile
    Victor Contreras
Mar 7, 2022

Aminoglycoside Dosing Based on PK/PD Characteristics Trial in Jerusalem (Aminoglycoside dose adjustment)

Recruiting
  • Aminoglycoside Dosing Based on PK/PD Characteristics
  • Aminoglycoside dose adjustment
  • Jerusalem, Israel
    Hadassah Hebrew University Medical Center
Nov 8, 2022

Gastro Esophageal Reflux Trial (Lansoprazole 15 mg, Lansoprazole 15mg/Calcium carbonate 600mg)

Not yet recruiting
  • Gastro Esophageal Reflux
  • Lansoprazole 15 mg
  • Lansoprazole 15mg/Calcium carbonate 600mg
  • (no location specified)
Sep 3, 2023

BPD - Bronchopulmonary Dysplasia, Pulmonary Hypertension, NEC Trial (L-Citrulline)

Not yet recruiting
  • BPD - Bronchopulmonary Dysplasia
  • +2 more
  • L-Citrulline
  • (no location specified)
Nov 23, 2022

Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)

Completed
  • Healthy Volunteers
  • CMAB007
  • Xolair
  • Shanghai, China
    Shanghai Xuhui Central Hospital
Jun 8, 2023

Alopecia Areata Trial (Ritlecitinib 20 mg)

Not yet recruiting
  • Alopecia Areata
  • Ritlecitinib 20 mg
  • (no location specified)
Dec 6, 2022

Safety Issues, Tolerability, Pharmacokinetics Trial (SB17170, Placebo)

Not yet recruiting
  • Safety Issues
  • +3 more
  • (no location specified)
Apr 2, 2023

Male, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in China (SS109)

Not yet recruiting
  • Male
  • +3 more
  • Hefei, China
  • +8 more
Aug 24, 2023

Rheumatoid Arthritis Trial (HLX01)

Completed
  • Rheumatoid Arthritis
  • (no location specified)
May 4, 2022

Solid Tumor, Adult Trial in Beijing, Shanxi, Shenzhen (ABO2011 Injection)

Recruiting
  • Solid Tumor, Adult
  • ABO2011 Injection
  • Beijing, China
  • +2 more
Oct 13, 2023